Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -53.21% | -11.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -53.21% | -11.41% | |||
| Cost of Revenue | 43.31% | -13.46% | |||
| Gross Profit | -101.42% | -10.43% | |||
| SG&A Expenses | -37.05% | 35.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.15% | 33.38% | |||
| Operating Income | 33.76% | -38.77% | |||
| Income Before Tax | -298.09% | 113.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -298.09% | 113.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -298.09% | 113.67% | |||
| EBIT | 33.76% | -38.77% | |||
| EBITDA | 34.30% | -40.06% | |||
| EPS Basic | -293.75% | 128.57% | |||
| Normalized Basic EPS | -290.00% | 100.00% | |||
| EPS Diluted | -293.75% | 1,700.00% | |||
| Normalized Diluted EPS | -290.00% | 900.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -70.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||